FDA approval of cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries

The US Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV — a big step toward making the drug…

The US Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV — a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries. The announcement was made on Monday morning by the manufacturer and organizations that helped to speed up development of the medication, called lenacapavir.